November 2016 Letter

This entry was posted in Letters on by .

Dear Friend of the BSF,

Although we have been quiet in our outreach this year, we have not been idle. Tremendous advances have been made on the clinical trial front with three therapeutic trials for primary brain tumors underway and a further three trials in the launch phase. The BSF has transitioned from supporting research initiatives to underwriting elements of multi-faceted and multi-institutional clinical trials. BSF funded investigator, Dr. Brastianos, is running a Meningioma trial in collaboration with the National Cancer Institute sponsored group called the Alliance. There are now more than 400 other entities throughout the U.S. participating. The principal physicians and researchers collaborating are tremendously hopeful that this trial will be a paradigm shift in the management of brain tumors.Read more on foundation medical updates below.

Due to popular demand, the Brain Science Foundation will once again host our Autumn Golf Tournament at Oyster Harbors Club in Osterville, MA on Monday, 18th September, 2017. The day will include 20-25 foursomes across eighteen holes in a scramble format with a shotgun start. There will be contests with prizes and awards presented at a cocktail and dinner reception following the tournament. There will also be a tennis tournament, weather permitting. All participants will be invited to join the festivities, including a silent auction. Most importantly, we will hear from renowned researchers and clinicians in the neurosciences that are a part of the leadership of the clinical trials that receive ongoing support from the BSF.

We are also in the process of updating the BSF website and will be migrating it to a new, more interactive, social and multimedia friendly platform. One example of what’s new is our ‘splash page‘, which gives a succinct overview of the BSF and the outstanding research that we support.

Foundation Medical Update:

At Massachusetts General Hospital:


We are supporting the work of Dr. Priscilla Brastianos, neuro-oncologist and physician scientist, whose research focuses on understanding the molecular mechanisms that drive primary and metastatic brain tumors. Dr. Brastianos is the Director of the Brain Metastasis Program at Massachusetts General Hospital, a unique scientific and clinical program with the primary objective of accelerating scientific findings into the patient clinics. She uses the latest genomic technology and analytic tools to comprehensively characterize the genomics of brain tumors, with a focus on understanding why tumors progress and metastasize.

Dr. Brastianos works with a team of national and international collaborators. The goal of her genomic studies is to arrive at a deep and precise understanding of the molecular pathways that drive the growth of brain tumors. This will then guide the development towards more rational, personalized, multi-faceted and effective therapeutic approaches. Her early pioneering work and novel discoveries, much of which was funded by BSF, now form the foundation of understanding which has enabled Dr Brastianos to initiate five unique clinical trials in primary and metastatic brain tumors, including trials of targeted therapies and immunotherapies. Dr. Brastianos’s clinical trial in meningiomas, which is funded by the Brain Science Foundation, is a national multicenter trial that is now open at more than 400 hospitals. Her work is historic! Dr. Brastianos’ trials in both primary and metastatic brain tumors are the first trials of their kind for personalized medicine applied to brain tumors! They represent a paradigm shift in the management of these common brain tumors. The clinical therapies now in trial have the potential to provide thousands of patients throughout the world an effective path towards treatment and, most importantly, hope for a cure.

 At Brigham and Women’s Hospital:


As the newly appointed Haley Distinguished Chair in the Neurosciences at Brigham and Women’s Hospital (BWH), Alexandra J. Golby, MD, is spearheading several different clinical and research efforts, with the aim of designing safer, less invasive, and more effective interventions for neurosurgery patients. She is director of image-guided neurosurgery at BWH and principal investigator of the Golby Lab-a surgical brain mapping laboratory at Harvard Medical School (HMS)-where she leads a research team focused on the application of preoperative and intraoperative imaging techniques to optimize neurosurgical care. Her clinical practice includes both stereotactic and image-guided neurosurgery, including special clinical interests in surgery for patients with epilepsy and brain tumors, particularly those whose pathology is intimately involved with critical brain regions. Her translational research connects the bench to the bedside, focusing on the use of structural and functional imaging techniques to guide neurosurgical planning and decision making, while harnessing the power of multiple imaging and brain mapping techniques.

Longstanding support from the Brain Science Foundation has allowed Dr. Golby to expand these efforts and take on additional leadership roles at BWH, including her role as co-director of clinical functional MRI. As co-director of AMIGO (Advanced Multimodality Image-Guided Operating Suite)-a state-of-the-art medical and surgical research environment that houses a complete array of advanced imaging equipment and interventional surgical systems-she continues to advance leading-edge research projects that stand to transform the field. She also supervises the image-guided neurosurgery fellow, ensuring that these techniques and advances are developed within the next generation of talented neurosurgeons. In recognition of her remarkable accomplishments in the field, she was recently promoted to Professor of Neurosurgery at HMS, in addition to her role there as Associate Professor of Radiology. Her appointment to the Haley Distinguished Chair will be effective February 1, 2017.

Fundraising Events:


Tee It Up for Brain Tumor Research,the BSF Golf & Tennis Classic, will be held on Monday, September 18th, 2017 at the Oyster Harbors Club in Osterville, Massachusetts. Golfers will enjoy 18 holes on Oyster Harbors’ picturesque course while tennis players participate in a round-robin format. The day will also include contests and an auction including items such as, artwork, sports & theater tickets, hotel nights, museum tickets, and sports memorabilia. Proceeds from this fundraiser will be allocated to the clinical trials for primary and metastatic brain tumors across collaborating medical institutions with leadership provided by physician researchers at MGH and BWH.

For early registration, please call 617-852-5230. Online registration will be open in the New Year. We hope you will be able to join us!

The Brain Science Foundation is so very proud to support the ongoing research to find cures, something not possible to do without the support of friends of the BSF. Please include us in your year-end giving plans and make a tax-deductible contribution online by clicking here or contact the Brain Science Foundation at, PO BOX 812701, Suite 203, Wellesley, MA 02482 or 617-852-5230.

From our family to yours, have a terrific holiday season!

With sincere appreciation,

Steven & Kathy Haley

BSF Co-Founders

To learn more please follow these links to Drs. Brastianos’s and Golby’s Labs:

Priscilla Brastianos, MD;

Alexandra Golby, MD;